Form 4: Oscar Health Director Sells Shares for Tax Obligations

Oscar Health Director Mario Schlosser sold 34,120 shares of Class A Common Stock to cover tax obligations from equity award vesting.

Summary

• Oscar Health, Inc. Director and 10% Owner Mario Schlosser reported the sale of 34,120 shares of Class A Common Stock.
• The sales occurred on June 2, 2026, with 24,452 shares sold at a weighted average price of $21.74 (ranging from $21.03 to $22.02) and 9,668 shares sold at a weighted average price of $22.45 (ranging from $22.03 to $22.96).
• These transactions were executed pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025.
• The stated purpose of the sales was to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
• Following these reported transactions, Mario Schlosser beneficially owns 480,866 shares of Oscar Health Class A Common Stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While it represents a reduction in insider ownership, the sale was pre-planned under a 10b5-1 plan and explicitly for tax purposes, which is a routine occurrence and generally not indicative of a negative outlook on the company's future.

Positives

• The sale was pre-planned under a Rule 10b5-1 plan, indicating it was not a discretionary sale based on new, non-public information.
• The explicit reason for the sale was to satisfy tax withholding obligations, which is a common and routine event for executives receiving equity compensation and generally not a signal of lack of confidence.

Negatives

• A director and 10% owner reduced their direct beneficial ownership by 34,120 shares.

Risks

• No specific risks are mentioned in this Form 4 beyond the general market perception of insider selling, even if for tax purposes.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Management Comments

• The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

Industry Context

StockSavvy.ai notes that insider sales executed under Rule 10b5-1 plans for tax withholding purposes are common practice in the healthcare technology and insurance sectors, where executive compensation often includes significant equity components. These types of sales are generally viewed as routine administrative events rather than signals of management's sentiment regarding the company's future prospects, differentiating them from discretionary open-market sales.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in a director's beneficial ownership, which is a routine event for equity compensation and typically has minimal impact on the broader shareholder base.
• Reporting Person (Mario Schlosser): The transaction allows the director to meet tax obligations arising from vested equity awards.

Key Dates

Recommendation

The reported transactions are routine, non-discretionary sales executed under a Rule 10b5-1 plan to cover tax obligations from equity award vesting. Such sales typically do not reflect a change in the insider's confidence in the company's long-term prospects and therefore do not warrant a change in investment recommendation based solely on this filing.

Keywords

Oscar Health, OSCR, Form 4, insider transaction, stock sale, director, equity awards, 10b5-1 plan, tax withholding